2-11669938-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_012344.4(NTSR2):c.192C>A(p.Arg64Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00191 in 1,518,268 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 6 hom. )
Consequence
NTSR2
NM_012344.4 synonymous
NM_012344.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.75
Genes affected
NTSR2 (HGNC:8040): (neurotensin receptor 2) The protein encoded by this gene belongs to the G protein-coupled receptor family that activate a phosphatidylinositol-calcium second messenger system. Binding and pharmacological studies demonstrate that this receptor binds neurotensin as well as several other ligands already described for neurotensin NT1 receptor. However, unlike NT1 receptor, this gene recognizes, with high affinity, levocabastine, a histamine H1 receptor antagonist previously shown to compete with neurotensin for low-affinity binding sites in brain. These activities suggest that this receptor may be of physiological importance and that a natural agonist for the receptor may exist. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 2-11669938-G-T is Benign according to our data. Variant chr2-11669938-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 2650687.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=2.75 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00120 AC: 182AN: 152176Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
182
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00135 AC: 154AN: 114318 AF XY: 0.00138 show subpopulations
GnomAD2 exomes
AF:
AC:
154
AN:
114318
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00199 AC: 2714AN: 1366092Hom.: 6 Cov.: 40 AF XY: 0.00191 AC XY: 1291AN XY: 674286 show subpopulations
GnomAD4 exome
AF:
AC:
2714
AN:
1366092
Hom.:
Cov.:
40
AF XY:
AC XY:
1291
AN XY:
674286
Gnomad4 AFR exome
AF:
AC:
10
AN:
29416
Gnomad4 AMR exome
AF:
AC:
18
AN:
31086
Gnomad4 ASJ exome
AF:
AC:
1
AN:
23586
Gnomad4 EAS exome
AF:
AC:
0
AN:
35146
Gnomad4 SAS exome
AF:
AC:
2
AN:
75988
Gnomad4 FIN exome
AF:
AC:
23
AN:
37694
Gnomad4 NFE exome
AF:
AC:
2565
AN:
1072038
Gnomad4 Remaining exome
AF:
AC:
95
AN:
56762
Heterozygous variant carriers
0
193
386
579
772
965
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00120 AC: 182AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.00109 AC XY: 81AN XY: 74350 show subpopulations
GnomAD4 genome
AF:
AC:
182
AN:
152176
Hom.:
Cov.:
32
AF XY:
AC XY:
81
AN XY:
74350
Gnomad4 AFR
AF:
AC:
0.000241266
AN:
0.000241266
Gnomad4 AMR
AF:
AC:
0.000850563
AN:
0.000850563
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0.000188466
AN:
0.000188466
Gnomad4 NFE
AF:
AC:
0.00226391
AN:
0.00226391
Gnomad4 OTH
AF:
AC:
0.00143403
AN:
0.00143403
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
NTSR2: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at